Small molecule HDAC inhibitors: Promising agents for breast cancer treatment

Meiling Huang(Chongqing Medical University), Rui Ling(Air Force Medical University), Juliang Zhang(Xijing Hospital), Xiaohui Li(Dalian University of Technology), Jian Zhang(University of South China), Changjiao Yan(Dalian University of Technology)
Bioorganic Chemistry
August 5, 2019
10.1016/j.bioorg.2019.103184
Cited by 76

Related Papers

Health benefits of qigong or tai chi for cancer patients: a systematic review and meta-analyses
|Complementary Therapies in Medicine|2013|209
Close relatives of MERS-CoV in bats use ACE2 as their functional receptors
|Nature|2022|162
Vitrified-warmed blastocyst transfer cycles yield higher pregnancy and implantation rates compared with fresh blastocyst transfer cycles—time for a new embryo transfer strategy?
|Fertility and Sterility|2011|154
Path planning of automated guided vehicles based on improved A-Star algorithm
|Unknown|2015|120
Meta-analysis of the effects of exercise intervention on quality of life in breast cancer survivors
|Breast Cancer|2014|116